Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The Cochrane Database of Systematic Reviews|February 17, 2012
Dietary supplements for established atopic eczemaFiona J Bath-Hextall, Claire Jenkinson, Rosemary Humphreys, et al.
The Journal of Investigative Dermatology|August 28, 2009
Characterization of p-phenylenediamine-albumin binding sites and T-cell responses to hapten-modified proteinClaire Jenkinson, Rosalind E Jenkins, Maja Aleksic, et al.
BMJ (Clinical Research Ed.)|August 20, 2009
Lifestyle interventions for knee pain in overweight and obese adults aged > or = 45: economic evaluation of randomised controlled trialGarry R Barton, Tracey H Sach, Claire Jenkinson, et al.
Medical Care|July 9, 2009
Comparing cost-utility estimates: does the choice of EQ-5D or SF-6D matter?Tracey H Sach, Garry R Barton, Claire Jenkinson, et al.
BMC Dermatology|October 30, 2013
Longitudinal, mixed method study to look at the experiences and knowledge of non melanoma skin cancer from diagnosis to one yearFiona Bath-Hextall, Claire Jenkinson, Arun Kumar, et al.
Health and Quality of Life Outcomes|July 16, 2008
Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores?Garry R Barton, Tracey H Sach, Claire Jenkinson, et al.
Toxicology Letters|January 13, 2009
Investigation of the immunogenicity of p-phenylenediamine and Bandrowski's base in the mouseJohn Farrell, Claire Jenkinson, Sidonie N Lavergne, et al.
Cost Effectiveness and Resource Allocation : C/E|July 21, 2009
Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee painGarry R Barton, Tracey H Sach, Anthony J Avery, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 3, 2007
An assessment of the discriminative ability of the EQ-5Dindex, SF-6D, and EQ VAS, using sociodemographic factors and clinical conditionsGarry R Barton, Tracey H Sach, Michael Doherty, et al.
Expert Review of Gastroenterology & Hepatology|November 7, 2014
Biomarkers for early diagnosis of pancreatic cancerClaire Jenkinson, Julie Earl, Paula Ghaneh, et al.
Pageof 2